newsfilter
← Latest News
GlobeNewswire·

OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director

LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain